ProfileGDS4132 / 202052_s_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 16% 22% 20% 18% 16% 17% 16% 17% 21% 21% 22% 21% 21% 19% 19% 19% 19% 19% 19% 22% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10133.68416
GSM201543Muscle PCOS pioglitazone 12142.856322
GSM201544Muscle PCOS pioglitazone 16146.969620
GSM201545Muscle PCOS pioglitazone 20144.306818
GSM201829Muscle PCOS pioglitazone 23136.484416
GSM201830Muscle PCOS pioglitazon 25138.069317
GSM201831Muscle PCOS pioglitazone 27129.411616
GSM201832Muscle PCOS pioglitazone 3138.441317
GSM201833Muscle PCOS pioglitazone 4145.617121
GSM201834Muscle PCOS pioglitazone 8142.9721
GSM201835Muscle PCOS after pioglitazone 10239.09122
GSM201836Muscle PCOS after pioglitazone 12240.095121
GSM201837Muscle PCOS after pioglitazone 16235.724921
GSM201838Muscle PCOS after pioglitazone 20236.841619
GSM201839Muscle PCOS after pioglitazone 23235.95919
GSM201840Muscle PCOS after pioglitazone 25239.931719
GSM201841Muscle PCOS after pioglitazone 27232.506619
GSM201842Muscle PCOS after pioglitazone 3232.764819
GSM201843Muscle PCOS after pioglitazone 4242.104819
GSM201844Muscle PCOS after pioglitazone 8246.284422